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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.06.013Objective: Studies examining the neuroprotective effects of off-pump coronary
artery bypass grafting have shown inconsistent results. Most studies, however, have
not differentiated between clampless and clamp off-pump techniques. The aim of
this study was to evaluate the effect of avoiding aortic manipulation on major
neurologic outcomes after off-pump coronary artery bypass grafting.
Methods: A total of 700 consecutive patients undergoing multiple-vessel off-pump
coronary artery bypass grafting between 2000 and 2003 were included. The 429
patients undergoing aortic no-touch technique were compared with 271 patients in
whom partial aortic clamps were applied. The aorta was screened by manual
palpation, and epiaortic ultrasonography was used selectively.
Results: The frequency of detected atherosclerotic aortic disease was higher in the
no-touch group (17.4% vs 5.1%, P  .0001). No-touch revascularization was
achieved with arterial conduits, arranged in T-graft or in situ configurations (50%).
The respective graft/patient ratios were 2.5  0.6 and 2.6  0.6 in the side-clamp
and no-touch groups (P  .009); however, revascularization of the posterolateral
myocardial territory was comparable (87% vs 90%, difference not significant). The
incidence of stroke (0.2% vs 2.2%, P .01) was significantly lower in the no-touch
group (1/429). Logistic regression identified partial aortic clamping as the only
independent predictor of stroke (odds ratio 28.5, confidence interval 0.22-333, P 
.009), increasing this risk 28-fold. Peripheral vascular disease (P  .068), diabetes
(P  .072), and history of stroke (P  .074) trended toward stroke.
Conclusions: Avoiding partial aortic clamping during off-pump coronary artery
bypass grafting provides superior neurologic outcome. The results are reproducible
and irrespective of the severity of aortic disease or the method of aortic screening.
This technique is recommended whenever technically feasible.
Although the death rates associated with cardiac operations havedeclined during the past decade, neurologic complications remaina substantial source of morbidity and mortality.1 Explanations forthis finding have focused on changing risk profiles in patient age,coexisting diseases, and diagnostic test use.1Embolic dislodgment of atherosclerotic plaques during surgical
aortic manipulations has been recognized as a major cause of stroke.2,3 Coronary
artery bypass grafting (CABG) done without CPB (off-pump CABG [OPCAB])
eliminates the risk of atheroemboli associated with aortic cannulation, crossclamp-
ing, and pump-related platelet aggregate emboli.4 Although it has been reported that
the risk of stroke is lowered by OPCAB,5,6 this benefit has been inconsistently
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CDdemonstrated7,8 and was not reproduced in a randomized
study.9-11 Most studies, however, have not differentiated
between OPCAB strategies with partial aortic clamps for
the construction of proximal aortic anastomoses and those
in which revascularization was performed without aortic
manipulation (no-touch technique).6-11 Compelling data
have shown that the placement and removal of these clamps
are linked to cerebral embolic load12 and thus the risk of
embolic stroke. Interestingly, studies evaluating the effect
of partial aortic clamping and, reciprocally, the neurologic
benefit in avoiding aortic manipulation have yielded con-
tradictory results.5,13 Subgroup analysis by Calafiore and
colleagues13 determined the subsequent risk of stroke, sug-
gesting that it compares to the risk after total aortic manip-
ulations required for on-pump CABG. Conversely, Patel
and coworkers5 have proposed that avoiding aortic manip-
ulation during OPCAB is not associated with improved
neurologic outcome. Thus the superiority of any OPCAB
technique in terms of major neurologic outcome in uns-
elected patients remains undetermined.
The use of arterial in situ or T configurations during
OPCAB allow clampless revascularization without any aor-
tic manipulation (aortic no-touch).5,14 The purpose of this
study was to compare major neurologic outcomes after
aortic no-touch versus side-clamp OPCAB techniques in the
general population. To avoid preselection for either OPCAB
or on-pump CABG and subsequent potential bias in patient
allocation, we limited our study cohort exclusively to pa-
tients undergoing OPCAB.
Patients and Methods
Study Design
The data from 700 consecutive patients who underwent isolated
OPCAB with multiple grafts between September 2000 and Sep-
tember 2003 were acquired. The 471 patients who were operated
on without aortic manipulation (no-touch group) were compared
with the 229 patients in whom partial aortic clamps were applied
during the construction of proximal aortic anastomoses (side-
clamp group). OPCAB procedures comprised 60% of the isolated
CABG operations performed during this period, and arterial re-
vascularization was applied in 75% of the patients.
Patients who underwent minimally invasive direct CABG and
those undergoing midsternotomy single graft anterior wall revas-
cularizations by in situ left internal thoracic artery (ITA) were not
included, to avoid preselection for the no-touch group. Proximal
mechanical connectors or clampless suture-based proximal devices
were not used in any of the patients.
The aorta was routinely screened by digital palpation. The
degree of aortic disease was graded in accordance with the criteria
of Mills and Everson.15 When this was graded as none or mild
(areas free of aortic disease easily identified), the patient was
considered eligible for both techniques and patient allocation was
based on technical considerations.16 No-touch OPCAB was fa-
vored when the extent of aortic disease was graded as moderate
(disease moderately extensive but with adequate disease-free ar-
308 The Journal of Thoracic and Cardiovascular Surgery ● Febreas) or severe (circumferential disease with no disease-free areas).
Thus by definition the prevalence and severity of aortic disease
were higher in the no-touch group.
Epiaortic ultrasonography was performed selectively. A 7.5-
MHz probe (Hewlett-Packard Company, Palo Alto, Calif) was
used when undetermined findings were encountered during digital
aortic palpation or when a high index of suspicion arose after chest
radiography or coronary angiography. The ultrasonographic find-
ings were evaluated by the surgeon himself.
All patients were routinely screened by carotid Doppler assess-
ments. The patients who required carotid endarterectomy (symp-
toms with unilateral stenosis 70% or symptoms with severe
bilateral stenosis) were excluded from this study.
Definition of Terms
Patients’ data were collected and analyzed according to the Society
of Thoracic Surgeons National Cardiac Surgery database guide-
lines and definitions (http://www.ctsnet.org/doc/4314). Operative
mortality was defined as death occurring within 30 days of the
operation. Neurologic complications were defined as any global or
focal neurologic deficit that was evident after emergence from
anesthesia and categorized as either permanent or reversible (tran-
sient ischemic attacks and prolonged reversible ischemic neuro-
logic deficit). All neurologic events were evaluated by a neurolo-
gist and further assessed by computed tomographic scan.
Surgical Technique and Postoperative Management
Operations were performed through midline sternotomy. Antico-
agulation was achieved with 2 mg/kg heparin, and the activated
clotting time was maintained above 300 seconds. The heart was
stabilized with a suction tissue stabilization system (Octopus;
Medtronic, Inc, Minneapolis, Minn). A deep pericardial retraction
suture was placed at the posterior fibrous pericardium medial to the
proximal part of the inferior vena cava to help manipulate and
rotate the heart to vertical and lateral positions. A right-sided
pericardial incision directed toward the inferior vena cava was
selectively performed to facilitate venous return. Vessel occlusion
was achieved by external encircling silicone rubber bands. Intra-
coronary shunts were used occasionally.
Grafting in the no-touch group was composed of arterial conduits
only. These included the left and right ITAs, the radial artery (RA),
and the right gastroepiploic artery (RGEA). The grafts were deployed
as left-sided in situ bilateral ITA or T configurations constructed of
bilateral ITA or left ITA-RA. The ITAs were routinely skeletonized,16
and dissection of the RA and the RGEA was facilitated by ultrasonic
scalpel (Harmonic Scalpel; Ethicon Endosurgery, Cincinnati Ohio).
The choice of configuration was determined by technical consider-
ations related to the conduits, as has been previously described for
conventional on-pump CABG.15 When T grafts were used, T anas-
tomoses were constructed before the distal coronary anastomoses.
The RGEA was always used as in situ graft.
Revascularization in the side-clamp group was achieved with
ITAs and saphenous vein grafts. All saphenous vein grafts were
attached to the aorta and constructed proximally after placement of
partial aortic clamp. Anterior wall revascularization was routinely
performed first in the sequence of grafting in both groups.
After the operation, all patients received intravenously admin-
istered isosorbide dinitrate (4-20 mg/h) for 2 days. Oral calcium-
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to patients who received RA or RGEA conduits and continued for
6 months. Antiplatelet therapy included aspirin at 250 mg/d (rec-
ommended for indefinite use) and clopidogrel at 75 mg/d (Plavix;
Sanofi Winthrop, Gentilly, France) for 6 postoperative weeks.
Data Analysis
The categoric variables were tested for group independence with
the 2 test. The results are expressed as the percentages and P
value. Numeric variables were compared with both the t test and
the nonparametric Mann-Whitney test. Data are expressed as mean
 SD with P value. Logistic regression was used to evaluate the
effect of preoperative and intraoperative descriptors on occurrence
of neurologic complications, early death, and the combined end
point of stroke or death. Results of logistic regression were ex-
pressed as odds ratio (OR) with associated 95% confidence inter-
val (CI) and P values. All analyses were performed with SPSS 11
software (SPSS Inc, Chicago, Ill).
Results
The baseline characteristics among the two groups were
comparable, with the exception of a higher prevalence of
renal dysfunction in the side-clamp group (Table 1). Oper-
ative data are listed in Table 2. The no-touch technique was
performed in 61% of the cases. The prevalence and severity
of aortic disease were greater in the no-touch group. Mod-
erate to severe atheromatous involvement was detected in
16.5% of these patients, whereas all but 3 patients (1%) in
the side-clamp group were free of involvement or had only
mild involvement (P  .0001). Despite a higher mean
TABLE 1. Preoperative characteristics
Variable
No-
(
Age (y)
Mean 67
Range
Age  80 y (No.) 5
Female (No.) 11
Hypertension (No.) 28
Diabetes (No.) 16
Peripheral vascular disease (No.) 7
Creatinine 2 mg/dL (No.) 2
Chronic lung disease (No.) 3
Acute myocardial infarction 1 wk (No.) 4
Congestive heart failure (No.) 6
Left main stenosis 50% (No.) 12
Three-vessel disease (No.) 39
Ejection fraction 35% (No.) 3
Emergency operation (No.) 2
Preoperative intra-aortic balloon pump (No.) 2
Previous cerebrovascular disease (No.) 4
Carotid disease (No.)
Moderate (50%–70% stenosis) 6
Severe (70% stenosis) 1number grafts in the side-clamp group (2.5  0.6 vs 2.6 
The Journal of Thoraci0.6, P  .009), revascularization of the posterolateral terri-
tory (the distribution of obtuse marginals or posterior de-
scending arteries) was comparable (Table 2).
Operative Mortality and Morbidity
Early mortality was lower in the no-touch group, although the
difference did not reach statistical significance (Table 3). The
EuroSCORE-predicted mortalities were 4.8%  8% (95% CI
0.055-0.073) and 4.3%  6% (95% CI 0.049-0.054) in the
no-touch and side-clamp groups, respectively (P .326). The
modes of death were cardiac-related (5 patients), sepsis (4
patients), acute abdominal ischemia (3 patients, of whom acute
mesenteric event was diagnosed during laparotomy in 2), and
acute aortic dissection (1 patient).
The incidence of major neurologic complications was sig-
nificantly higher in the side-clamp group (1/429 or 0.2% vs
2.2% or 6/271, P  .01; Table 3). The types and distribution
of neurologic deficits were as follows: permanent (stroke) in 5
patients and prolonged reversible ischemic neurologic deficit
in 2 patients, in the right cerebral hemisphere in 4 patients and
the left cerebral hemisphere in 3 patients. Two patients who
had strokes had been regarded by the surgeon as being free of
aortic disease, and in 3 patients with stroke the aorta was
considered mildly involved.
Prediction of Neurologic Complications and Mortality
The surgical technique including use of partial aortic clamp
(OR 28.5, 95% CI 0.22-333, P  .009,) was identified as
group
29)
Side-clamp group
(n  271) P value
.235
11.5 68.4  10.9
4 40–92
.1%) 27 (10.0%) .233
.3%) 81 (30.0%) .436
.0%) 166 (61.7%) .253
.4%) 108 (40.0%) .873
.3%) 39 (14.4%) .304
%) 35 (13%) .001
%) 24 (8.9%) .999
.3%) 19 (7%) .144
.9%) 47 (17.4%) .589
.2%) 79 (29.3%) .756
%) 254 (93.7%) .710
%) 21 (7.7%) .992
%) 21 (7.8%) .528
%) 16 (5.9%) .932
%) 23 (8.5%) .632
.6%) 54 (19.9%) .142
%) 8 (2.9%) .613touch
n  4
.4 
33–9
6 (13
7 (27
3 (66
9 (39
4 (17
5 (5.8
8 (8.9
4 (10
8 (15
0 (28
9 (93
3 (7.7
8 (6.5
6 (6.1
1 (9.6independent predictor for neurologic complications. Periph-
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CDeral vascular disease (P  .068), history of cerebrovascular
disease (P  .074), and diabetes (P  .072) tended to
predict neurologic complications (Table 4). Emergency op-
eration (OR 8.7, 95% CI 1.99-38.3, P  .004) and renal
dysfunction (OR 11.5, 95% CI 3.02-43.8, P  .0001) were
identified as correlates of mortality (Table 4). The use of
TABLE 2. Operative data
Variable
No-touch
(n 
Epiaortic ultrasonography (No.) 21 (4.
Grafts/patient
Mean 2.5 
Range 2–
Atherosclerotic aorta (No.) 75 (17
Aortic grading (No.)
Moderate atherosclerosis 45 (10
Severe atherosclerosis 26 (6.
Use of left ITA (No.) 427 (99
Use of right ITA (No.) 245 (57
Use of bilateral ITA (No.) 236 (55
Use of RA (No.) 174 (40
Use of RGEA (No.) 27 (6.
Use of saphenous vein graft (No.) 5 (1.
T grafts (No.) 213 (49
Sequential grafting (No.) 155 (36
Bilateral ITA cross configuration (No.) 146 (34
Grafts to posterolateral territory (No.) 388 (90
Target coronary vessel (No.)
Left anterior descending 429 (40
Diagonal 101 (9.
Circumflex 354 (33
Right 31 (2.
Posterior descending 157 (14
TABLE 3. Early results
Variable
No-touch group
(n  429)
Hospital stay (d)
Mean  SD 5.5  4.2
Range 0–20
Early death (No.) 9 (2.1%)
Myocardial infarction (No.) 6 (1.4%)
Atrial fibrillation (No.) 62 (14.8%)
Re-exploration for bleeding (No.) 5 (1.2%)
Renal failure* (No.) 16 (3.8%)
Sternal infection (No.)
Deep 4 (0.9%)
Superficial 10 (2.3%)
Major neurologic event (No.) 1 (0.2%)
Neurologic event or death (No.) 10 (2.4%)
*Defined as serum creatinine level 2 mg/dL or more, or postoperative incpartial aortic clamping tended to predict the occurrence of
310 The Journal of Thoracic and Cardiovascular Surgery ● Febrneurologic complications or mortality (OR 2.55, 95% CI
0.96-6.75, P  .060).
Discussion
The findings of this study suggest that avoiding partial
aortic clamping enhances the neuroprotective effect of
p Side-clamp group
(n  271) P value
52 (19%) .0001
.009
2.6  0.6
2–5
14 (5.1%) .0001
3 (1.1%) .0001
0 (0%) .0009
269 (99.2%) .642
83 (30.6%) .0001
83 (30.6%) .0001
8 (2.9%) .0001
1 (0.4%) .0001
261 (96.7%) .0001
30 (11.1%) .0001
28 (10.3%) .0001
58 (21.4%) .0001
236 (87.1%) .164
271 (40%)
58 (8.6%) .510
156 (23%) .0001
34 (5%) .182
158 (23.3%) .0001
Side-clamp group
(n  271)
Total
(n  700) P value
.166
5.9  3.6 5.7  4
0–24 0–24
7 (2.6%) 16 (2.3%) .679
4 (1.5%) 10 (1.5%) .936
39 (14.8%) 101 (14.8%) .991
5 (1.9%) 10 (1.5%) .448
16 (6.0%) 32 (4.7%) .166
1 (0.4%) 5 (0.7%) .388
15 (5.5%) 25 (3%) .026
6 (2.2%) 7 (1.0%) .010
13 (4.9%) 23 (3.3%) .072
of 1 mg/dL.grou
429)
8%)
0.6
4
.4%)
.4%)
1%)
.5%)
.1%)
.3%)
%)
3%)
2%)
.7%)
.2%)
%)
.4%)
%)
4%)
.4%)
8%)OPCAB. This benefit was reproducible and attained irre-
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CDspective of the severity of aortic disease or the method of
aortic screening. It has been shown that the no-touch tech-
nique can be implemented in most OPCAB procedures and
that routine use of arterial conduits for this purpose is
feasible.
Refinements in surgical techniques and the advent of
tissue stabilizers have markedly reduced blood pressure
fluctuations and the subsequent risk of stroke during off-
pump displacement of the beating heart.17 Partial aortic
clamping, however, remains a potential cause for embolic
stroke during OPCAB. Post-OPCAB stroke rates ranging
from 0% to 3.3% have been reported.5-11,14,17-19 This wide
range may reflect differences in patient profiles but may also
stem from different operative strategies, such as the choice
of graft deployment and aortic screening methods.
In this study, the low 1% overall incidence of major
neurologic complications stemmed from the differential ef-
fect of the no-touch technique. There was 1 neurologic
event among the 429 consecutive patients in the no-touch
OPCAB group (0.2%). To date, data on the benefit of
avoiding partial aortic clamps during OPCAB are sparse;
however, our results validate previous reports of low stroke
rates in corresponding no-touch OPCAB subgroups (0.5%,5
0.4%14 and 0%20,21). This consistent reduction in the inci-
dence of stroke below 1% may reflect on the reproducibility
of the no-touch technique. Our results should be viewed in
with respect to the relatively old age of the patient cohort
(Table 1). Preoperative risk factors of stroke—history of
cerebrovascular disease,22 peripheral vascular disease,23 di-
abetes,23 and hypertension,24 and carotid disease—were
evenly distributed between the groups. After adjustment for
confounding factors, the use of partial aortic clamping was
TABLE 4. Logistic regression: Independent risk factors for
Variable
Stroke
OR 95% CI P value
Age 1.05 0.93–1.18 .397
Sex 6.65 0.60–73.5 .122
Diabetes 6.89 0.60–56.6 .072
Hypertension — — —
Peripheral vascular disease 6.16 0.87–43.5 .680
Renal failure 1.19 0.04–31.3 .913
Chronic lung disease 0 0.00–5.40 .943
Cerebrovascular disease 5.56 0.84–36.4 .074
Atrial fibrillation 0 0.00–1.30 .926
Congestive heart failure 1.59 0.13–19.1 .712
Left main disease 3.86 0.68–21.7 .126
Emergency operation 0 0.00–1.40 .931
Operative variables
Use of bilateral ITA 2.52 0.38–16.7 .338
Use of side-clamp 28.5 2.27–333.3 .009found to be the only independent predictor of stroke, in-
The Journal of Thoracicreasing this risk 28-fold. Consistent with previous obser-
vations,22,23 history of cerebrovascular disease, peripheral
vascular disease, and diabetes tended to predict stroke.
The 2.2% neurologic event rate observed our side-clamp
group is compatible with stroke rates reported after previous
OPCAB series.5-11,14,17-19 In our study, as well as in previ-
ous studies of corresponding subgroups, it is likely that
certain cases of atherosclerotic aortic disease were undetec-
ted and resulted in stroke. Epiaortic ultrasonography has
been established as the modality of choice for aortic screen-
ing,25 with manual palpation linked to a higher frequency of
underdetection. It is apparent that in this study a suboptimal
detection rate was achieved (Table 2), because the reported
frequency of significantly atheromatous aorta detected in
epiaortic ultrasonographic studies ranges from 21% to
62%.25,26 Epiaortic ultrasonography during OPCAB has
been reported to be useful in making the decision to deploy
grafts on the ascending aorta and in making adjustments in
the location of side-clamps once ultrasonographic findings
have been detected.27 This, however, remains a problem
considering that the frequency of atherosclerotic anterior
wall aortic findings that indicate surgical modifications may
reach 35%, and in 25% of patients undergoing OPCAB,
revascularization without aortic manipulation may be even-
tually required.27 Despite the efficacy of epiaortic ultra-
sonography,25-27 not all strokes may be prevented by it. The
decisions concerning surgical modifications are made on the
basis of qualitative ultrasonographic information and are
usually based on the surgeon’s evaluation; thus the potential
for errors is not obviated. The wide range of ultrasono-
graphic detection rates (21%-62%) is a cause of con-
cern,25,26 and a major limitation is the fact that ultrasonog-
ke, death, and combined outcome of stroke or death
Death Stroke or death
OR 95% CI P value OR 95% CI P value
.06 0.99–1.15 .081 1.06 1.00–1.13 .039
.51 0.14–1.82 .303 0.95 0.33–2.72 .929
.92 0.26–3.23 .903 1.38 1.00–3.77 .520
.40 0.36–5.47 .621 2.21 0.66–7.43 .197
.26 0.32–4.95 .731 1.87 0.64–5.37 .244
.5 3.02–43.8 .0001 7.55 2.39–23.8 .001
— — — — — —
.06 0.36–11.7 .412 2.77 0.81–9.45 .102
.3 0.22–7.47 .762 0.77 0.15–3.95 .761
.1 0.20–5.83 .906 1.04 0.27–4.02 .947
.41 0.10–1.62 .208 0.94 0.34–2.57 .913
.74 1.99–38.3 .004 3.81 1.02–14.1 .045
.24 0.63–7.89 .209 2.06 0.75–5.65 .157
.04 0.30–3.55 .939 2.55 0.96–6.75 .600stro
1
0
0
1
1
11
2
1
1
0
8
2raphy is not always available. At the time of our study
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the standard of care and was reserved for select high-risk
patients. This policy has been apparently applied by many
other centers as well.6 Mechanical or suture-based clamp-
less proximal connectors are other options that have been
contemplated for reducing the risk of atheroembolism dur-
ing OPCAB while allowing some degree of aortic manipu-
lation.28 Several concerns, however, have recently been
raised. Embolic particulate debris after the use of anasto-
motic devices is still evident,29 and the safety of these
devices remains unresolved after reports of device-related
early graft closure.30 No-touch OPCAB may therefore be
still the modification of choice once aortic disease has been
ultrasonographically detected.
In this study, the term “no-touch grafting” denotes total
arterial revascularization. The literature does not offer a
clear mandate for routine composite attachment of venous
grafts. Despite several exceptions to this rule,19 arterial
conduits, arranged in composite or in situ configurations,
are usually required for this purpose.5,16,20 Our results dem-
onstrate that this strategy can be implemented for most
patients undergoing OPCAB.
Several limitations of this study need to be addressed.
Under the assumption that failure to detect atherosclerotic
aortic plaques resulted in stroke, a comparative study with
systematic epiaortic ultrasonography for all patients is war-
ranted. This study is restricted in the ability to detect mul-
tiple predictors of neurologic events because only 7 such
events occurred in this series. In addition, a comparative
prospective randomized trial is required to validate our
results. The reproducible results conferred by the no-touch
technique, however, remain indisputable. We could not
differentiate between the effect of single versus multiple
aortic side-clamps on stroke. Relevant issues for further
assessment would be the role of newly available clampless
proximal anastomotic devices and the effect of no-touch
OPCAB on neurocognitive outcomes.
In conclusion, the aortic no-touch OPCAB technique
provides superior neurologic outcome irrespective of the
aortic screening strategy or the severity of atherosclerotic
disease. This technique should be considered whenever
technically feasible.
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